Axsome Therapeutics (AXSM) plans to raise $52 million in an initial public offering on the week of November 16th. The company will be issuing 4,300,000 shares at a price of $11.00-$13.00 per share. Ladenburg Thalmann and Cantor Fitzgerald & Co. acted as the underwriters for the IPO. Axsome Therapeutics provided the following description of their […]